Skip to ContentSkip to Navigation
How to find us dr. H. Boer


Genome-wide association study of cardiovascular disease in testicular cancer patients treated with platinum-based chemotherapy

Insulin-like factor 3, luteinizing hormone and testosterone in testicular cancer patients: effects of β-hCG and cancer treatment

Survivorship care after testicular cancer: New insights in late effects of treatment and approaches to shared-care follow-up

Single-nucleotide polymorphism in the 5-alpha-reductase gene (SRD5A2) is associated with increased prevalence of metabolic syndrome in chemotherapy-treated testicular cancer survivors

Vascular fingerprint and vascular damage markers associated with vascular events in testicular cancer patients during and after chemotherapy

Growth Differentiation Factor 15 (GDF-15) Plasma Levels Increase during Bleomycin- and Cisplatin-Based Treatment of Testicular Cancer Patients and Relate to Endothelial Damage

High risk vascular fingerprint in patients treated with cisplatin-based chemotherapy for testicular cancer

Long-term exposure to circulating platinum is associated with late effects of treatment in testicular cancer survivors

Easy navigating through the forest of survivorship care

Long-Term and Late Effects of Germ Cell Testicular Cancer Treatment and Implications for Follow-Up

Read more